Avacta Expands Following Aptuscan Acquisition
News Jul 09, 2012
Avacta Group has expanded its Yorkshire headquarters with the addition of new laboratory, office and manufacturing space.
The move, which follows the recent acquisition of affinity reagents specialist Aptuscan, brings together the entire Avacta Group on the same site.
The new facilities, which include purpose built laboratories, are at Avacta’s existing Thorp Arch Estate premises in Wetherby, UK, and have been taken on to accommodate the Company’s current rapid expansion.
Alastair Smith, Chief Executive of Avacta, commented: “Our core businesses are seeing strong growth, and recent funding, together with the acquisition of Aptuscan, will ensure we are able to accelerate our existing product development pipeline. Thorp Arch Estate is an ideal location for biotechnology enterprises, with excellent transport connections, and we are enthusiastic about plans to create a wider science park facility here.”
Quotient Clinical Signs Cocrystal Agreement with NuformixNews
Partnership to evaluate cocrystal formulations using translational pharmaceutics.READ MORE
SYGNIS AG Announces Completion of Relocation of its Innova Biosciences UnitNews
Move forms part of integration into SYGNIS Group.READ MORE
DataArt Joins Biotechnology Association BIO DeutschlandNews
Global technology consultancy DataArt announced today that it has joined BIO Deutschland, Germany's biotechnology industry association.READ MORE